Press Releases | Longboard Pharmaceuticals

Skip to main navigation

Corporate Menu

About
Our Approach
Patients
Investors
Longboard Life
Contact

Press Releases

Year

November 29, 2022

Longboard Pharmaceuticals’ Presence at American Epilepsy Society (AES) Annual Meeting Reinforces Ongoing Commitment to the Rare Epilepsy Community

November 8, 2022

Longboard Pharmaceuticals to Present at Guggenheim’s Healthcare Talks 4th Annual Immunology and Neurology Day

November 3, 2022

Longboard Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2022 Financial Results

September 29, 2022

Longboard Pharmaceuticals to Participate in the Cantor Neurology & Psychiatry Conference

September 1, 2022

Longboard Pharmaceuticals to Participate in Upcoming Investor Conferences

August 4, 2022

Longboard Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2022 Financial Results

August 3, 2022

Longboard Pharmaceuticals to Present at the 2022 Wedbush PacGrow Healthcare Virtual Conference

June 7, 2022

Longboard Pharmaceuticals to Present at the JMP Securities 2022 Life Sciences Conference on June 15

June 1, 2022

Longboard Pharmaceuticals to Participate in Five Upcoming Epilepsy-Focused Conferences this Summer

May 12, 2022

Longboard Pharmaceuticals to Participate in Upcoming Investor Events

Pagination

Current page 1
Page 2
Next page
Last page

Displaying 1 - 10 of 17

©2022 Longboard Pharmaceuticals Privacy Policy | Terms of Use

Corporate Menu

About
Our Approach
Patients
Investors
Longboard Life
Contact